Patents by Inventor Vipan DHALL

Vipan DHALL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240139109
    Abstract: The pharmacokinetic profile of the SGLT2 inhibitor bexagliflozin can be improved by formulating it as an extended release tablet. Compared with standard immediate-release dosage forms these tablets can permit a lower peak plasma concentration, Cmax, while maintaining plasma concentrations at therapeutic levels for a desired period. This can be used, for instance, to administer lower doses while still providing the same pharmacological effect.
    Type: Application
    Filed: November 3, 2023
    Publication date: May 2, 2024
    Inventors: Feng WANG, Ankit SHRIVASTAVA, Rina SHAH, Brian SEED, Vinay PATIL, Michael J. HADD, Fuxia DONG, Vipan DHALL, Chunfeng DAI, Joseph Ho-Lun CHAU, Qiuhua CAI
  • Publication number: 20220117898
    Abstract: The pharmacokinetic profile of the SGLT2 inhibitor bexagliflozin can be improved by formulating it as an extended release tablet. Compared with standard immediate-release dosage forms these tablets can permit a lower peak plasma concentration, Cmax, while maintaining plasma concentrations at therapeutic levels for a desired period. This can be used, for instance, to administer lower doses while still providing the same pharmacological effect.
    Type: Application
    Filed: October 5, 2021
    Publication date: April 21, 2022
    Inventors: Feng WANG, Ankit SHRIVASTAVA, Rina SHAH, Brian SEED, Vinay PATIL, Michael J. HADD, Fuxia DONG, Vipan DHALL, Chunfeng DAI, Joseph Ho-Lun CHAU, Qiuhua CAI
  • Patent number: 11260055
    Abstract: The present invention relates to an oral pharmaceutical composition, particularly a tablet, comprising an active ingredient lurasidone or its pharmaceutically acceptable salt(s) or solvate(s) thereof and one or more pharmaceutical excipient(s); and a process for its preparation.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: March 1, 2022
    Assignee: PIRAMAL ENTERPRISES LIMITED
    Inventors: Tejas Shah, Milan B. Agrawal, Narendra Patel, Devesh Bhatt, Umesh Barabde, Vipan Dhall
  • Publication number: 20200046695
    Abstract: The present invention relates to an oral pharmaceutical composition, particularly a tablet, comprising an active ingredient lurasidone or its pharmaceutically acceptable salt(s) or solvate(s) thereof and one or more pharmaceutical excipient(s); and a process for its preparation.
    Type: Application
    Filed: January 10, 2018
    Publication date: February 13, 2020
    Applicant: PIRAMAL ENTERPRISES LIMITED
    Inventors: Tejas SHAH, Milan B. AGRAWAL, Narendra PATEL, Devesh BHATT, Umesh BARABDE, Vipan DHALL
  • Publication number: 20180344648
    Abstract: A pharmaceutical composition comprising clobazam or its pharmaceutically acceptable salt(s) or solvate(s) thereof of defined particle size and one or more pharmaceutically acceptable excipients is described. A method for preparing the composition is also described.
    Type: Application
    Filed: November 29, 2016
    Publication date: December 6, 2018
    Applicant: PIRAMAL ENTERPRISES LIMITED
    Inventors: Vipan DHALL, Aravind KERUDI, Tapan BUCH, Ajay SAV
  • Publication number: 20170000799
    Abstract: The present invention relates to solid particles of a poorly soluble drug, pharmaceutical compositions comprising them and processes for their preparation. The compositions according to the present invention show an improved dissolution profile while being stable.
    Type: Application
    Filed: December 19, 2014
    Publication date: January 5, 2017
    Inventors: Ziauddin TYEBJI, Meghal MISTRY, Inder GULATI, Vipan DHALL